171 related articles for article (PubMed ID: 38526693)
1. From Skin to Solution: Exploring Epicutaneous Immunotherapy for Peanut Allergy-A Systematic Review and Meta-Analysis.
Banatwala UESS; Nasir MM; Javed R; Ahmed A; Farhan SA; Ajam A
Clin Rev Allergy Immunol; 2024 Apr; 66(2):125-137. PubMed ID: 38526693
[TBL] [Abstract][Full Text] [Related]
2. The Efficacy and Safety of Epicutaneous Immunotherapy for Allergic Diseases: A Systematic Review and Meta-Analysis.
Xiong L; Lin J; Luo Y; Chen W; Dai J
Int Arch Allergy Immunol; 2020; 181(3):170-182. PubMed ID: 31801149
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of epicutaneous immunotherapy with DBV712 (peanut patch) in peanut allergy.
Dupont C; Burks AW; Fleischer DM; Bee KJ; Chainani S; Sampson HA
Expert Rev Clin Immunol; 2024 Jun; 20(6):623-633. PubMed ID: 38323337
[TBL] [Abstract][Full Text] [Related]
4. Allergen-specific oral immunotherapy for peanut allergy.
Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
Cochrane Database Syst Rev; 2012 Sep; (9):CD009014. PubMed ID: 22972130
[TBL] [Abstract][Full Text] [Related]
5. Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results.
Fleischer DM; Shreffler WG; Campbell DE; Green TD; Anvari S; Assa'ad A; Bégin P; Beyer K; Bird JA; Brown-Whitehorn T; Byrne A; Chan ES; Cheema A; Chinthrajah S; Chong HJ; Davis CM; Ford LS; Gagnon R; Greenhawt M; Hourihane JO; Jones SM; Kim EH; Lange L; Lanser BJ; Leonard S; Mahler V; Maronna A; Nowak-Wegrzyn A; Oriel RC; O'Sullivan M; Petroni D; Pongracic JA; Prescott SL; Schneider LC; Smith P; Staab D; Sussman G; Wood R; Yang WH; Lambert R; Peillon A; Bois T; Sampson HA
J Allergy Clin Immunol; 2020 Oct; 146(4):863-874. PubMed ID: 32659313
[TBL] [Abstract][Full Text] [Related]
6. Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety.
Chu DK; Wood RA; French S; Fiocchi A; Jordana M; Waserman S; Brożek JL; Schünemann HJ
Lancet; 2019 Jun; 393(10187):2222-2232. PubMed ID: 31030987
[TBL] [Abstract][Full Text] [Related]
7. Advances in the management of peanut allergy (oral immunotherapy and epicutaneous immunotherapy).
Wang J
Allergy Asthma Proc; 2020 Jan; 41(1):5-9. PubMed ID: 31888777
[No Abstract] [Full Text] [Related]
8. Targeted allergen-specific immunotherapy within the skin improves allergen delivery to induce desensitization to peanut.
Landers JJ; Janczak KW; Shakya AK; Zarnitsyn V; Patel SR; Baker JR; Gill HS; O'Konek JJ
Immunotherapy; 2022 May; 14(7):539-552. PubMed ID: 35196877
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy approaches for peanut allergy.
Kim EH; Patel C; Burks AW
Expert Rev Clin Immunol; 2020 Feb; 16(2):167-174. PubMed ID: 31928251
[No Abstract] [Full Text] [Related]
10. Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy.
Mondoulet L; Dioszeghy V; Ligouis M; Dhelft V; Dupont C; Benhamou PH
Clin Exp Allergy; 2010 Apr; 40(4):659-67. PubMed ID: 20002446
[TBL] [Abstract][Full Text] [Related]
11. Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial.
Fleischer DM; Greenhawt M; Sussman G; Bégin P; Nowak-Wegrzyn A; Petroni D; Beyer K; Brown-Whitehorn T; Hebert J; Hourihane JO; Campbell DE; Leonard S; Chinthrajah RS; Pongracic JA; Jones SM; Lange L; Chong H; Green TD; Wood R; Cheema A; Prescott SL; Smith P; Yang W; Chan ES; Byrne A; Assa'ad A; Bird JA; Kim EH; Schneider L; Davis CM; Lanser BJ; Lambert R; Shreffler W
JAMA; 2019 Mar; 321(10):946-955. PubMed ID: 30794314
[TBL] [Abstract][Full Text] [Related]
12. Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults.
Jones SM; Sicherer SH; Burks AW; Leung DY; Lindblad RW; Dawson P; Henning AK; Berin MC; Chiang D; Vickery BP; Pesek RD; Cho CB; Davidson WF; Plaut M; Sampson HA; Wood RA;
J Allergy Clin Immunol; 2017 Apr; 139(4):1242-1252.e9. PubMed ID: 28091362
[TBL] [Abstract][Full Text] [Related]
13. Treatment of gastric eosinophilia by epicutaneous immunotherapy in piglets sensitized to peanuts.
Mondoulet L; Kalach N; Dhelft V; Larcher T; Delayre-Orthez C; Benhamou PH; Spergel J; Sampson HA; Dupont C
Clin Exp Allergy; 2017 Dec; 47(12):1640-1647. PubMed ID: 28960628
[TBL] [Abstract][Full Text] [Related]
14. Epicutaneous peanut patch device for the treatment of peanut allergy.
Langlois A; Graham F; Bégin P
Expert Rev Clin Immunol; 2019 May; 15(5):449-460. PubMed ID: 30864861
[TBL] [Abstract][Full Text] [Related]
15. Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial.
Sampson HA; Shreffler WG; Yang WH; Sussman GL; Brown-Whitehorn TF; Nadeau KC; Cheema AS; Leonard SA; Pongracic JA; Sauvage-Delebarre C; Assa'ad AH; de Blay F; Bird JA; Tilles SA; Boralevi F; Bourrier T; Hébert J; Green TD; Gerth van Wijk R; Knulst AC; Kanny G; Schneider LC; Kowalski ML; Dupont C
JAMA; 2017 Nov; 318(18):1798-1809. PubMed ID: 29136445
[TBL] [Abstract][Full Text] [Related]
16. Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results.
Pongracic JA; Gagnon R; Sussman G; Siri D; Oriel RC; Brown-Whitehorn TF; Green TD; Campbell DE; Anvari S; Berger WE; Bird JA; Chan ES; Cheema A; Chinthrajah RS; Chong HJ; Dowling PJ; Fineman SM; Fleischer DM; Gonzalez-Reyes E; Kim EH; Lanser BJ; MacGinnitie A; Mehta H; Petroni D; Rupp N; Schneider LC; Scurlock AM; Sher LD; Shreffler WG; Sindher SB; Stillerman A; Wood R; Yang WH; Bois T; Sampson HA; Bégin P
J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1864-1873.e10. PubMed ID: 34848381
[TBL] [Abstract][Full Text] [Related]
17. Specific epicutaneous immunotherapy prevents sensitization to new allergens in a murine model.
Mondoulet L; Dioszeghy V; Puteaux E; Ligouis M; Dhelft V; Plaquet C; Dupont C; Benhamou PH
J Allergy Clin Immunol; 2015 Jun; 135(6):1546-57.e4. PubMed ID: 25583102
[TBL] [Abstract][Full Text] [Related]
18. The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice.
Dioszeghy V; Mondoulet L; Dhelft V; Ligouis M; Puteaux E; Dupont C; Benhamou PH
Clin Exp Allergy; 2014 Jun; 44(6):867-81. PubMed ID: 24666588
[TBL] [Abstract][Full Text] [Related]
19. Estimated risk reduction to packaged food reactions by epicutaneous immunotherapy (EPIT) for peanut allergy.
Remington BC; Krone T; Kim EH; Bird JA; Green TD; Lack G; Fleischer DM; Koppelman SJ
Ann Allergy Asthma Immunol; 2019 Nov; 123(5):488-493.e2. PubMed ID: 31442495
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of epicutaneous immunotherapy for food allergy.
Wang J; Sampson HA
Pediatr Allergy Immunol; 2018 Jun; 29(4):341-349. PubMed ID: 29369411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
